These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes. Gans EH; Kligman AM J Dermatolog Treat; 2002 Sep; 13(3):107-10. PubMed ID: 12227872 [TBL] [Abstract][Full Text] [Related]
5. Development and in-vitro characterization of fish oil oleogels containing benzoyl peroxide and salicylic acid as keratolytic agents. Rehman K; Tan CM; Zulfakar MH Drug Res (Stuttg); 2014 Mar; 64(3):159-65. PubMed ID: 24026957 [TBL] [Abstract][Full Text] [Related]
7. The microsponge delivery system of benzoyl peroxide: preparation, characterization and release studies. Jelvehgari M; Siahi-Shadbad MR; Azarmi S; Martin GP; Nokhodchi A Int J Pharm; 2006 Feb; 308(1-2):124-32. PubMed ID: 16359833 [TBL] [Abstract][Full Text] [Related]
8. Factors affecting the morphology of benzoyl peroxide microsponges. Nokhodchi A; Jelvehgari M; Siahi MR; Mozafari MR Micron; 2007; 38(8):834-40. PubMed ID: 17692528 [TBL] [Abstract][Full Text] [Related]
9. The utility of benzoyl peroxide in hydrophase base (Brevoxyl) in the treatment of acne vulgaris. Weinberg JM J Drugs Dermatol; 2006 Apr; 5(4):344-9. PubMed ID: 16673802 [TBL] [Abstract][Full Text] [Related]
10. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes. Leyden JJ Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851 [TBL] [Abstract][Full Text] [Related]
11. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Rolland A; Wagner N; Chatelus A; Shroot B; Schaefer H Pharm Res; 1993 Dec; 10(12):1738-44. PubMed ID: 8302759 [TBL] [Abstract][Full Text] [Related]
12. The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. Embil K; Nacht S J Microencapsul; 1996; 13(5):575-88. PubMed ID: 8864994 [TBL] [Abstract][Full Text] [Related]
18. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study. Leyden J; Kaidbey K; Levy SF Am J Clin Dermatol; 2001; 2(4):263-6. PubMed ID: 11705253 [TBL] [Abstract][Full Text] [Related]
19. Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide. Dubina MI; Fleischer AB Arch Dermatol; 2009 Sep; 145(9):1027-9. PubMed ID: 19770443 [TBL] [Abstract][Full Text] [Related]
20. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. Lookingbill DP; Chalker DK; Lindholm JS; Katz HI; Kempers SE; Huerter CJ; Swinehart JM; Schelling DJ; Klauda HC J Am Acad Dermatol; 1997 Oct; 37(4):590-5. PubMed ID: 9344199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]